- Human pathology

Home > A. Molecular pathology > Targeted therapy > Small molecules > XL647-A


Sunday 1 January 2012

See also

- multitargeted tyrosine kinase inhibitors (TKIs)


- XL647-A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib. Pietanza MC, Lynch TJ Jr, Lara PN Jr, Cho J, Yanagihara RH, Vrindavanam N, Chowhan NM, Gadgeel SM, Pennell NA, Funke R, Mitchell B, Wakelee HA, Miller VA. J Thorac Oncol. 2012 Jan;7(1):219-226. PMID: 22011666